News

Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.

By Dave Muoio November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia. These comments were accompanied by the official kickoff of CHIEF-HF,...
By Laura Lovett November 18, 2019
This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.  The acquisition will include Biovotion’s clinical grade-wearable...

The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to clinicians and healthcare providers in the US.

By Tammy Lovell November 18, 2019
UK-based health technology firm Ultromics has received clearance from the US Food and Drug Administration (FDA) for its cardiovascular image analysis system, EchoGo Core. EchoGo applies artificial intelligence (AI) to automate the analysis and quantification of ultrasound-based heart scans. The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to...
By Dave Muoio November 17, 2019
A half dozen digital health startups went head to head this weekend in a pitch contest hosted by the American Heart Association. The competition’s cohort ranged from well-known heavy hitters like Welldoc to Korean hospital spinout Vuno, but in the end it was Pittsburgh-based Forest Devices that claimed top honors from both the contest’s eight judges and its audience. “Our solution is AlphaSTROKE...
By Melissa Jankowski November 15, 2019
About the author: Melissa Jankowski is the executive director of The Non-Emergency Medical Transportation Accreditation Commission (NEMTAC), a non-profit organization dedicated to ensuring safe medical transportation. NEMTAC partners with medical transport brokers and associations to develop best practices and has a role in the establishment of American National Standards that affect the industry...
By Dave Muoio November 15, 2019
The increased spotlight on Google’s healthcare privacy practices doesn’t seem to be letting up, with the Washington Post publishing a story this morning detailing a botched arrangement between the tech giant and the National Institutes of Health back in 2017. The two groups had a research arrangement centered on more than 100,000 chest X-ray images provided to Google by the NIH. However,...
By Dave Muoio November 15, 2019
Livongo is touting new data regarding the efficacy of its device-and-coaching disease management platform, this time among those using its Livongo for Hypertension and Livongo for Diabetes products together. The results, which are set to be formally presented this weekend at the American Heart Association Scientific Sessions 2019, identified significant decreases in hypertensive blood pressure as...
By Laura Lovett November 15, 2019
Following a slew of vaping-related deaths and other emerging health concerns, Apple has announced that it will pull down all 181 vaping apps from the App Store, Axios first reported.  "We take great care to curate the App Store as a trusted place for customers, particularly youth, to download apps. We’re constantly evaluating apps, and consulting the latest evidence, to determine risks to users’...

Credit: Neeuro

By Dean Koh November 14, 2019
A personalized, interactive brain-training game will soon be helping children with Attention Deficit Hyperactivity Disorder (ADHD) improve their attention span. The advantage of this technology is that that children with ADHD can participate in this program from home. A pilot run for the home-based program will be launched for 20 children, aged 6-12 years, who are currently receiving treatment...

Editor's Pick